Literature DB >> 30391394

Models of osteoarthritis: the good, the bad and the promising.

P J Cope1, K Ourradi2, Y Li3, M Sharif4.   

Abstract

Osteoarthritis (OA) is a chronic degenerative disease of diarthrodial joints most commonly affecting people over the age of forty. The causes of OA are still unknown and there is much debate in the literature as to the exact sequence of events that trigger the onset of the heterogeneous disease we recognise as OA. There is currently no consensus model for OA that naturally reflects human disease. Existing ex-vivo models do not incorporate the important inter-tissue communication between joint components required for disease progression and differences in size, anatomy, histology and biomechanics between different animal models makes translation to the human model very difficult. This narrative review highlights the advantages and disadvantages of the current models used to study OA. It discusses the challenges of producing a more reliable OA-model and proposes a direction for the development of a consensus model that reflects the natural environment of human OA. We suggest that a human osteochondral plug-based model may overcome many of the fundamental limitations associated with animal and in-vitro models based on isolated cells. Such a model will also provide a platform for the development and testing of targeted treatment and validation of novel OA markers directly on human tissues. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal-model; Osteoarthritis; Osteochondral plugs; ex-vivo model; in-vivo model

Year:  2018        PMID: 30391394      PMCID: PMC6350005          DOI: 10.1016/j.joca.2018.09.016

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


Introduction

Osteoarthritis (OA) is a chronic degenerative disease of diarthrodial joints, predominantly affecting the spine and peripheral joints of the body, particularly the hands, hips, knees and feet. OA most commonly affects people over the age of forty, with the risk of disease increasing with age. OA is a complex heterogeneous disease with different clinical and biochemical phenotypes. The cause(s) of OA are unknown, and many studies have suggested that the pathobiology of OA is far more complex than a simple cartilaginous or bone disease. It is now acknowledged that OA affects many joint structures, including degeneration of cartilage, abnormal bone remodelling and synovial inflammation1, 2. Also, studies have shown that there is a complex interplay between the different joint components, making understanding of the degradative sequence of events involved in OA pathogenesis very difficult to dissect3, 4, 5. The initial onset of OA disease is considered due to an imbalance between the cartilage degradation and repair process6, 7. The exact sequence of events that trigger the onset of the disease is however widely debated throughout the literature. One hypothesis, suggests that secretion of pro-inflammatory cytokines into the synovial joint induces matrix metalloproteinases which cause the fragmentation and degradation of cartilage extracellular matrix leading to bone remodelling and synovitis8, 9, 10. Contrary to this theory, some studies suggest that subchondral bone remodelling and synovitis precede articular degeneration in the early stages of OA8, 11, 12. While other studies suggest that meniscal degeneration evolving through fibrillation of tissue and a decrease in the levels of type I and II collagen within the meniscus, act as a predisposing or contributing factor to OA progression13, 14. In the later stages of OA, formation of subchondral cysts, subchondral sclerosis and osteophytes occur as a direct result of bone remodelling, cartilage degradation and synovitis15, 16, 17. Treatment of OA is largely symptomatic due to insufficient understanding of aetiopathogenesis hindering the development of suitable disease-modifying drugs. This makes targeted treatment of OA a distinct challenge. Human OA tissue samples are usually collected for research once end stages of the disease have been reached, for example during joint replacement, by which time destructive changes in the joint are well established. This makes studying the early disease process very challenging. OA pathology, particularly early OA, is therefore very difficult to study, and so researchers turn to in-vivo and ex-vivo preclinical animal models to investigate early pathological changes in OA. These models offer unique advantages as well as limitations for studying human OA. This article will review the different models used for investigation of OA, discuss their advantages and disadvantages, and propose development of a gold standard model for OA that closely reflects natural human disease.

Current models used in OA research

OA research models can be categorised into either ex-vivo or in-vivo models. Depending on the research question, different models can be used to address different aspects of OA development and progression. Each model has its advantages, yet it has become clear that no single model provides the opportunity to study the disease as a whole. The different models currently used in OA research are discussed below.

Ex-vivo models

Ex-vivo models can be categorised into monolayer culture, co-culture, three-dimensional (3D) culture and explant-based culture. Each model has its advantages and disadvantages and so can be used to answer different questions in OA research. Ex-vivo models such as monolayer culture and co-culture are easier and cheaper to produce than 3D cell cultures and explant-based models. Monolayer cultures are also easy to produce on a large scale and avoid the challenges associated with culturing different cell types at different conditions. However, monolayer and co-cultures are limited in their use due to the fact that they isolate only one or two tissue components at a time. Many studies have shown that there is a strong interplaying network of communication between different joint components that help regulate and maintain a healthy joint, and so isolation of specific joint components hinders this communication3, 19, 20. For example, healthy articular cartilage is dependent upon the release of soluble factors by subchondral bone, and interactions between chondrocytes and synovial fluid ensures the flow of growth factors, regulatory peptides and nutrients between them19, 20. When injured cartilage is co-cultured with synovium, a protective effect is produced on the synoviocytes. Similarly, culture of subchondral bone and cartilage separately results in increased chondrocyte death and cartilage degradation as well as decreased protein content in culture media compared to when cultured together3, 19, 22. Explant models and 3D cell cultures allow for this inter-tissue communication and so are arguably more useful models available to OA researchers to reproduce natural in-vivo environments. Despite this, these models are more difficult to produce in terms of tissue volume and maintaining cell viability over extended periods of time. Some of the advantages, disadvantages and applications of various ex-vivo models used in OA research are summarised in Table I.
Table I

A summary of the advantages and disadvantages of different ex-vivo models used in OA research

Ex-vivo ModelAdvantagesDisadvantagesExample of the application of the model in OA research
Monolayer culture

A large number of cells can be easily produced from a single sample23

The configuration of cells cultured in a monolayer layout allows homogenous spread of nutrients and growth factor from the culture medium24

Limited for certain tissue types such as cartilage, whose phenotype changes once in a monolayer culture environment, introducing inter-experimental variability25, 26

Chondrocytes are very sensitive to their molecular environment and so need to remain in contact with the extracellular matrix to ensure that they reflect natural in-vivo samples23

Cartilage has low cellularity, therefore, a large sample of cartilage is required to ensure sufficient numbers of cells are present to carry out a reliable experiment23

Isolating a tissue in culture removes all systemic influences on that tissue, which does not reflect natural joint tissue

Cells in monoculture traditionally grow on a flat surface in glass or plastic flasks and so do not allow for growth in all directions, as seen in the natural 3D in-vivo environment24

Monolayer cultures can be used to study the effects of cytokine stimulation and osmotic pressure23

Synovial cell cultures useful to study the role of the synovium in OA

Co-culturing cells

Co-culturing cells of different lineages is important to allow for changes in cell-specific physiology and cell–cell interactions that are important in regulating cell and tissue physiology23, 27

Different conditions are required for culturing each cell type23

Co-culturing cells can result in alterations of phenotype when cells are isolated23

Co-cultures traditionally grow on a flat surface in glass or plastic flasks and so do not allow for growth in all directions, as seen in the natural 3D in-vivo environment24

Co-culturing cells can be used to study the effects of cytokine stimulation and osmotic pressure23

Osteoblast-chondrocyte co-culture useful in understanding bone-cartilage cross-talk28

Co-culturing chondrocytes and osteoblasts results in greater cell growth, matrix production and deposition as well as reduced glycosaminoglycan deposition compared to culturing chondrocytes alone29, 30

Co-culturing sclerotic osteoarthritic osteoblasts and chondrocytes from osteoarthritic articular cartilage results in an increased shift towards chondrocyte hypertrophy and release of matrix metalloproteinases and aggrecanases31, 32

Culturing synovium and cartilage together produce very different results in terms of the break-down of proteoglycan and matrix structure compared to when cultured alone4

Co-culturing synovium and injured cartilage produces a protective effect on synoviocytes21

Synovium-cartilage cultures useful to study the role of the synovium in OA

Co-culture of bone components ensure balanced bone remodelling5

3D cell culture

3D cell culture allows for culture of different cell lines and important cell–cell interactions

3D cell cultures grow as aggregates or spheroids in a matrix, allowing growth in all directions, similar to the natural in-vivo environment24

The 3D structure provides structural strength to sensitive cells23

The proliferation rate of cells tends to be slower in 3D cell cultures compared to 2D cultures33

The structural strength provided to cultured cells depends on the scaffold used23

3D cell culture can be used to study the effects of cytokine stimulation and osmotic pressure, as well as the effects of physical injury and loading on tissue23

A matrix structure of collagens and proteoglycans favours phenotypically normal cartilage28

Explant based models

Simple, cheap and easy to produce23

Explant models allow for the natural processes that occur within the extracellular matrix environment to be observed26

Cell death often occurs at the explant edge

Only a limited number of cells can be extracted from a single source

Limited tissue availability and significant inter-experimental variability23

Explant based models can be used to study the effects of cytokine stimulation and osmotic pressure, as well as the effects of physical injury and biomechanical loading on tissue23, 28

Synovial tissue explants useful to study the role of the synovium in OA

A summary of the advantages and disadvantages of different ex-vivo models used in OA research A large number of cells can be easily produced from a single sample The configuration of cells cultured in a monolayer layout allows homogenous spread of nutrients and growth factor from the culture medium Limited for certain tissue types such as cartilage, whose phenotype changes once in a monolayer culture environment, introducing inter-experimental variability25, 26 Chondrocytes are very sensitive to their molecular environment and so need to remain in contact with the extracellular matrix to ensure that they reflect natural in-vivo samples Cartilage has low cellularity, therefore, a large sample of cartilage is required to ensure sufficient numbers of cells are present to carry out a reliable experiment Isolating a tissue in culture removes all systemic influences on that tissue, which does not reflect natural joint tissue Cells in monoculture traditionally grow on a flat surface in glass or plastic flasks and so do not allow for growth in all directions, as seen in the natural 3D in-vivo environment Monolayer cultures can be used to study the effects of cytokine stimulation and osmotic pressure Synovial cell cultures useful to study the role of the synovium in OA Co-culturing cells of different lineages is important to allow for changes in cell-specific physiology and cell–cell interactions that are important in regulating cell and tissue physiology23, 27 Different conditions are required for culturing each cell type Co-culturing cells can result in alterations of phenotype when cells are isolated Co-cultures traditionally grow on a flat surface in glass or plastic flasks and so do not allow for growth in all directions, as seen in the natural 3D in-vivo environment Co-culturing cells can be used to study the effects of cytokine stimulation and osmotic pressure Osteoblast-chondrocyte co-culture useful in understanding bone-cartilage cross-talk Co-culturing chondrocytes and osteoblasts results in greater cell growth, matrix production and deposition as well as reduced glycosaminoglycan deposition compared to culturing chondrocytes alone29, 30 Co-culturing sclerotic osteoarthritic osteoblasts and chondrocytes from osteoarthritic articular cartilage results in an increased shift towards chondrocyte hypertrophy and release of matrix metalloproteinases and aggrecanases31, 32 Culturing synovium and cartilage together produce very different results in terms of the break-down of proteoglycan and matrix structure compared to when cultured alone Co-culturing synovium and injured cartilage produces a protective effect on synoviocytes Synovium-cartilage cultures useful to study the role of the synovium in OA Co-culture of bone components ensure balanced bone remodelling 3D cell culture allows for culture of different cell lines and important cell–cell interactions 3D cell cultures grow as aggregates or spheroids in a matrix, allowing growth in all directions, similar to the natural in-vivo environment The 3D structure provides structural strength to sensitive cells The proliferation rate of cells tends to be slower in 3D cell cultures compared to 2D cultures The structural strength provided to cultured cells depends on the scaffold used 3D cell culture can be used to study the effects of cytokine stimulation and osmotic pressure, as well as the effects of physical injury and loading on tissue A matrix structure of collagens and proteoglycans favours phenotypically normal cartilage Simple, cheap and easy to produce Explant models allow for the natural processes that occur within the extracellular matrix environment to be observed Cell death often occurs at the explant edge Only a limited number of cells can be extracted from a single source Limited tissue availability and significant inter-experimental variability Explant based models can be used to study the effects of cytokine stimulation and osmotic pressure, as well as the effects of physical injury and biomechanical loading on tissue23, 28 Synovial tissue explants useful to study the role of the synovium in OA

In-vivo models

Many animal models in at least eighteen different species have been developed to study established pathological features of OA such as pain, synovitis, cartilage degeneration and bone remodelling. Animal models used in OA research (see Table II) can be categorised into either induced or spontaneous models. Induced models refer to models where OA disease (or OA like features) have been induced either chemically or surgically. On the other hand, spontaneous models are subcategorised into naturally occurring and genetically modified models that develop OA.
Table II

A summary of the different animal models used in OA research

Species/ModelSpontaneousSurgically inducedChemically InducedExamples of the application of the model in OA research
MouseNaturally occurring OA1, 2, 34

Genetic models:

PAR2−/−, CD4−/−, MMP17−/−, Tenascin C−/-, Ddr2−/−, SulPhatase−/- 1/2, Syndecan 4−/−, Fgf2−/−, Mmp13−/−,Hif2a+/-, GDF5+/−, Osteopontin, Ptges1, Tnfrsf11b+/-, Runx 2+/−, ADAMTS-5/4 −/−, Adamts5−/−, ADAMTS4−/−, MMP3−/−, ICE−/-, IL-1β−/-, iNOS −/−35

Transgenic models2, 36

Mutations in type II collagen gene1Brtl mouse37Mouse Del1: Short deletion in type II collagen18Col9a1 knockout36STR/ORT + C57/BL6 strains1, 2, 36, 38, 39, 40

Anterior cruciate ligament transection (ACLT)18, 34, 41, 42, 43

Articular groove model34

Intra-articular tibial plateau fracture, cyclic articular cartilage tibial compression, anterior cruciate ligament, rupture via tibial compression overload2

Ovariectomy34

Partial discectomy44

Medial partial meniscectomy34

Destabilisation of medial meniscus, meniscectomy, tibial overload, fracture models34

Meniscal destabilisation34, 38, 40, 43

ACLT and removal of medial/lateral meniscus or transection of posterior/medial/lateral collateral ligament34

Mono-iodoacetate (MIA) intra-articular injection34, 40

Steroids, cytokines34, 40

Papain34, 40

Collagenase34, 40, 41

Mouse models widely used for toxicology testing.1

Mouse models used to study the molecular basis of OA.45

Genetically modified mouse models used to investigate the genetic factors and specific genes involved in cartilage degeneration, bone remodelling and inflammation2, 18, 43, 45

Rat

Naturally occurring OA uncommon18, 41

ACLT34, 41, 46

Medial meniscectomy (MMx)34, 40, 41, 46

Articular groove model34

Medial meniscal transection (MMT)1, 34, 41, 45

Combination surgery40

Ovariectomy34, 40, 41

Partial medial meniscectomy45

Immobilization40

ACL injury47

Intra-articular injection of steroids, cytokines40

Collagenase40, 41

Iodoacetate injection18, 34, 40, 41, 45, 48

Papain34, 40, 41

Immunotoxin41

Rat model useful in toxicology testing of pharmaceutical compounds1. MMT, medial collateral ligament transection (MCLT) and iodoacetate induced models used to study pain40, 45

Rat undergone partial medial meniscectomy are useful in cartilage restoration techniques45

Syrian hamster

Naturally occurring OA1, 34

Transgenic models1

Syrian hamster OA models are naturally occurring, and transgenic models are used to study pathogenesis of OA1

Guinea pig

Naturally occurring OA2, 34, 39, 40, 41, 45, 49

Transgenic models1

Naturally occurring OA in medial compartment of knee joint in Dunkin Hartley guinea pigs1, 18

ACLT40, 41

MCLT, osteotomy, patellectomy, sciatic neurectomy41

Meniscal transection1, 34

Ovariectomy34, 41

MMx41, 50

Combination surgery40

Immunotoxin, papain, collagenase, copper II bisglycinate, lipopolysaccharide, chondromucoprotein41

MIA34, 41

Quinolone34

Transgenic guinea pig models used to study pathogenesis of OA1

Guinea pig models used to study age and BMI associated risk factors in OA49. Dunkin Hartley guinea pig used in therapeutic and pathogenic studies of knee OA51. Guinea pigs induced by medial meniscal tear and spontaneous OA models used to study slow and rapidly progressive OA34

Cat

ACLT40

Useful in pain studies2

Rabbit

Naturally occurring OA2, 52

ACLT, MMx, posterior cruciate ligament transection (PCLT), patellectomy34, 39, 40, 41

ACL tear45

Section of medial collateral and both cruciate ligaments, resection of medial meniscus53

Immobilization40

Combination surgery, impact loading, cartilage scarification40

ACLT, ACLT and PCL/MCL34

Ovariectomy34

Articular groove34

Partial and MMx1, 34, 39, 45

Transarticular mechanical impact on patellofemoral joint, femoral condyle impact2

Intra-articular injection of steroids and cytokines40

Papain34, 40, 54, 55

Allogeneic cartilage particles56

Iodoacetate and collagenase40, 41

Quinolone34

Chymopapain, trypsin, IL-1β, chondroitinase, vitamin A, fibronectin fragments41

Rabbit models useful in efficacy testing of various compounds such as hyaluronic acid45.

Partial meniscectomy models used in testing chondroprotective agents1

Canine

Naturally occurring OA2, 34, 41

Abrasion, valgus osteotomy, pelvic osteotomy, cartilage defect41

Cranial cruciate ligament transection57

Articular groove34, 41, 58

ACLT1, 2, 41, 45, 58, 59

Partial medial and MMx34, 41

Immobilization1, 40

Impact loading, cartilage scarification40

ACLT60

Groove model in femoral condyle

Transarticular impact to stifle34, 58

MIA, papain, calcium pyrophosphate crystals34, 41

Allogeneic cartilage particles61

MMx model useful in toxicology testing and ACLT model used to study slow progression of OA and pathogenesis that mimics naturally occurring disease1

Canine models that naturally develop OA have been used in therapeutic intervention preclinical trials2

Transarticular impact models were used to identify whether osteoarthritic changes originate from cartilage or subchondral bone changes34 and to study early changes in OA in articular cartilage due to joint impact trauma34

ACLT induced model have been used in identification of OA biomarkers45

Caprine

-Naturally occurring OA41

MCLT, ACLT41

MMx34, 39, 41, 45, 62

Articular groove34

Unilateral medial MMx, unilateral MCL, meniscal transection, cartilage scarification, unilateral ACLT63

Goat models used to study cartilage repair45

Ovine

Naturally occurring OA2

Lateral meniscectomy, ACLT, MCLT41

Articular groove model34

MMx34, 39, 40, 41, 45, 62

Bilateral and unilateral Mx, unilateral ACLT, medial MMx, unilateral MCLT, unilateral radial meniscal tear, unilateral caudal pole hemi-meniscectomy, unilateral medial meniscectomy63

Ovariectomy34, 40

Ovine models used to study early OA cartilage changes, meniscus changes and related treatment techniques45, 64

Equine

Naturally occurring OA2, 45

Post carpal fracture, exercise-induced41

Trauma to medial femur and tibia65

Metacarpophalangeal ligament transection41

Osteochondral fragment66

Articular groove model34

Amphotericin, E. coli lipopolysaccharide, IL-1, carrageenan41

Monosodium iodoacetate40, 41, 48

Filipin34, 41, 67

Lipopolysaccharide68

Amphotericin69

Polyvinyl alcohol foam particles41, 70

Papain40

Intra-articular injection of steroids, collagenase, cytokines40

Equine models used to study articular cartilage repair, osteochondral defects and naturally occurring bone remodelling2

Zebrafish

Genetic knockout e.g. COL10A171

Zebrafish model useful in studying gene related pathology of OA71

Porcine

Post-fracture72

ACLT, ovariectomy, ACL reconstruction, articular groove model34

Arthroscopy

Cartilage resurfacing

Surgically in miniature pigs:

ACLT and ACL reconstruction41

Porcine model used to study repair and regeneration of focal cartilage defects73

Bovine

Naturally occurring OA in patella74, 75

ACLT34

Non-human primates

Naturally occurring OA1, 34, 76

Naturally occurring OA in macaques34, 40, 77, 78

Transgenic models1

Meniscectomy34, 40

Ovariectomy in macaques40, 77, 79

Ovariectomy in cynomolgus monkeys34

Collagenase induced in cynomolgus monkeys80

Naturally occurring and transgenic models of non-human primates used to study general features of OA1

A summary of the different animal models used in OA research Genetic models: Transgenic models2, 36 Anterior cruciate ligament transection (ACLT)18, 34, 41, 42, 43 Articular groove model Intra-articular tibial plateau fracture, cyclic articular cartilage tibial compression, anterior cruciate ligament, rupture via tibial compression overload Ovariectomy Partial discectomy Medial partial meniscectomy Destabilisation of medial meniscus, meniscectomy, tibial overload, fracture models Meniscal destabilisation34, 38, 40, 43 ACLT and removal of medial/lateral meniscus or transection of posterior/medial/lateral collateral ligament Mono-iodoacetate (MIA) intra-articular injection34, 40 Steroids, cytokines34, 40 Papain34, 40 Collagenase34, 40, 41 Mouse models widely used for toxicology testing. Mouse models used to study the molecular basis of OA. Genetically modified mouse models used to investigate the genetic factors and specific genes involved in cartilage degeneration, bone remodelling and inflammation2, 18, 43, 45 Naturally occurring OA uncommon18, 41 ACLT34, 41, 46 Medial meniscectomy (MMx)34, 40, 41, 46 Articular groove model Medial meniscal transection (MMT)1, 34, 41, 45 Combination surgery Ovariectomy34, 40, 41 Partial medial meniscectomy Immobilization ACL injury Intra-articular injection of steroids, cytokines Collagenase40, 41 Iodoacetate injection18, 34, 40, 41, 45, 48 Papain34, 40, 41 Immunotoxin Rat model useful in toxicology testing of pharmaceutical compounds. MMT, medial collateral ligament transection (MCLT) and iodoacetate induced models used to study pain40, 45 Rat undergone partial medial meniscectomy are useful in cartilage restoration techniques Naturally occurring OA1, 34 Transgenic models Syrian hamster OA models are naturally occurring, and transgenic models are used to study pathogenesis of OA Naturally occurring OA2, 34, 39, 40, 41, 45, 49 Transgenic models Naturally occurring OA in medial compartment of knee joint in Dunkin Hartley guinea pigs1, 18 ACLT40, 41 MCLT, osteotomy, patellectomy, sciatic neurectomy Meniscal transection1, 34 Ovariectomy34, 41 MMx41, 50 Combination surgery Immunotoxin, papain, collagenase, copper II bisglycinate, lipopolysaccharide, chondromucoprotein MIA34, 41 Quinolone Transgenic guinea pig models used to study pathogenesis of OA Guinea pig models used to study age and BMI associated risk factors in OA. Dunkin Hartley guinea pig used in therapeutic and pathogenic studies of knee OA. Guinea pigs induced by medial meniscal tear and spontaneous OA models used to study slow and rapidly progressive OA ACLT Useful in pain studies Naturally occurring OA2, 52 ACLT, MMx, posterior cruciate ligament transection (PCLT), patellectomy34, 39, 40, 41 ACL tear Section of medial collateral and both cruciate ligaments, resection of medial meniscus Immobilization Combination surgery, impact loading, cartilage scarification ACLT, ACLT and PCL/MCL Ovariectomy Articular groove Partial and MMx1, 34, 39, 45 Transarticular mechanical impact on patellofemoral joint, femoral condyle impact Intra-articular injection of steroids and cytokines Papain34, 40, 54, 55 Allogeneic cartilage particles Iodoacetate and collagenase40, 41 Quinolone Chymopapain, trypsin, IL-1β, chondroitinase, vitamin A, fibronectin fragments Rabbit models useful in efficacy testing of various compounds such as hyaluronic acid. Partial meniscectomy models used in testing chondroprotective agents Naturally occurring OA2, 34, 41 Abrasion, valgus osteotomy, pelvic osteotomy, cartilage defect Cranial cruciate ligament transection Articular groove34, 41, 58 ACLT1, 2, 41, 45, 58, 59 Partial medial and MMx34, 41 Immobilization1, 40 Impact loading, cartilage scarification ACLT Groove model in femoral condyle Transarticular impact to stifle34, 58 MIA, papain, calcium pyrophosphate crystals34, 41 Allogeneic cartilage particles MMx model useful in toxicology testing and ACLT model used to study slow progression of OA and pathogenesis that mimics naturally occurring disease Canine models that naturally develop OA have been used in therapeutic intervention preclinical trials Transarticular impact models were used to identify whether osteoarthritic changes originate from cartilage or subchondral bone changes and to study early changes in OA in articular cartilage due to joint impact trauma ACLT induced model have been used in identification of OA biomarkers -Naturally occurring OA MCLT, ACLT MMx34, 39, 41, 45, 62 Articular groove Unilateral medial MMx, unilateral MCL, meniscal transection, cartilage scarification, unilateral ACLT Goat models used to study cartilage repair Naturally occurring OA Lateral meniscectomy, ACLT, MCLT Articular groove model MMx34, 39, 40, 41, 45, 62 Bilateral and unilateral Mx, unilateral ACLT, medial MMx, unilateral MCLT, unilateral radial meniscal tear, unilateral caudal pole hemi-meniscectomy, unilateral medial meniscectomy Ovariectomy34, 40 Ovine models used to study early OA cartilage changes, meniscus changes and related treatment techniques45, 64 Naturally occurring OA2, 45 Post carpal fracture, exercise-induced Trauma to medial femur and tibia Metacarpophalangeal ligament transection Osteochondral fragment Articular groove model Amphotericin, E. coli lipopolysaccharide, IL-1, carrageenan Monosodium iodoacetate40, 41, 48 Filipin34, 41, 67 Lipopolysaccharide Amphotericin Polyvinyl alcohol foam particles41, 70 Papain Intra-articular injection of steroids, collagenase, cytokines Equine models used to study articular cartilage repair, osteochondral defects and naturally occurring bone remodelling Genetic knockout e.g. COL10A1 Zebrafish model useful in studying gene related pathology of OA Post-fracture ACLT, ovariectomy, ACL reconstruction, articular groove model Arthroscopy Cartilage resurfacing Surgically in miniature pigs: ACLT and ACL reconstruction Porcine model used to study repair and regeneration of focal cartilage defects Naturally occurring OA in patella74, 75 ACLT Naturally occurring OA1, 34, 76 Naturally occurring OA in macaques34, 40, 77, 78 Transgenic models Meniscectomy34, 40 Ovariectomy in macaques40, 77, 79 Ovariectomy in cynomolgus monkeys Collagenase induced in cynomolgus monkeys Naturally occurring and transgenic models of non-human primates used to study general features of OA Smaller animal models of OA such as mice, rats, rabbits and guinea pigs are much easier, quicker, cheaper and more readily available than larger animal models such as horses, pigs and dogs2, 40. Smaller animals can be handled and housed with greater ease than larger models, but due to their smaller size, tissue samples extracted are much smaller and therefore tend to differ to a greater extent in their anatomical and histological structure when compared to humans. Larger animal models therefore provide many advantages over the use of smaller animal models in terms of their greater anatomical similarity to the human model. A dog's articular cartilage for example is half the thickness of a humans, whereas that of a mouse is a minimum of 70 times thinner2, 18. Additionally, a wider range of tests can be performed on larger animals, such as repeated synovial fluid collection and imaging. They also have a longer life span allowing for slower disease progression and time to end stage OA, as seen in humans. Whilst slow progressive models most accurately reflect human OA, they are however more expensive and time consuming to conduct. There are also greater ethical considerations around the use of larger animal models such as non-human primates and canines. Based on this, some animal models are therefore better suited to OA research than others, such as the canine, caprine, bovine and porcine models. Some of the advantages and disadvantages of various animal species used in OA research are summarised in Table III.
Table III

A summary of the advantages and disadvantages of different animal models used in OA research

Animal ModelAdvantagesDisadvantages
Mouse

Mice have a short life span (generally one or 2 years) and so develop OA fairly rapidly, making mice an easy model to study the whole disease process18, 43

Small animal size means the whole joint can be histologically sectioned81

Mice are easily managed, with low maintenance cost, demonstrate rapid disease onset and their complete genome is available for study40

Genetically modified mouse models are easy to produce and are useful to investigate the genetic factors involved in OA pathogenesis, specifically genes involved in cartilage degeneration, bone remodelling and inflammation18, 45

Mouse models can be used in toxicology testing and to establish the molecular basis of OA1, 45

Huge variation in results observed between different strains of mice18

Disease severity varies with age, with older mice more representative of human disease82

Difficult to ascertain skeletal maturity as growth plates often do not close completely82

Mice are anatomically and histologically different to humans, for example, mice have a thicker layer of calcified cartilage, do not have three distinct chondrocyte layers and have a cartilage seventy times thinner than humans45

Macroscopic lesions and degrees of damage are difficult to identify due to the small anatomical size of mice81

The progression and process of disease is faster in mice than in humans (weeks rather than decades)36

The small size of mice makes surgically inducing OA more challenging40

Postoperative management of mice is difficult in surgically induced models40, 45

Rat

Rat cartilage is thicker than that of mice, so it is possible to induce partial and full-thickness cartilage defects1, 45

Rats rarely experience post-operative infection so are useful animal models to surgically induce OA1

Rats are easily managed and require low maintenance costs40, 45

It is easier to perform surgery in rats than in mice due to their larger size40

The full rat genome is available for study40

MMT, MCL transection and iodoacetate models useful to study pain40, 45

Rat models useful in toxicology testing and studying cartilage restoration techniques1, 45

Naturally occurring OA is uncommon in rats, variation in results is often observed between different strains of rat and disease severity varies with age, with older rats tending to present with more severe OA18

It is difficult to ascertain the skeletal maturity of rats83

Rats have greater volumes of highly vascularised adipose tissue and muscle in the medial knee region

Post-operative rats immediately resume load-bearing which accelerates joint degeneration1

Genetically engineered rat models are not available and postoperative management of rats is challenging45

Guinea Pig

The guinea pig model has similar OA histopathology to disease in humans84

Guinea pigs are large enough that tissue samples can be easily collected for tests and the whole joint can be histologically sectioned49

Guinea pigs are easy to manage40

Naturally occurring guinea pig models are available and the disease pathogenesis is predictable and similar to that seen in humans1, 45

-Hartley guinea pigs can be used to study risk factors for OA such as BMI and age

Complete guinea pig genome available85

The weight of each guinea pig and whether they are housed alone or in pairs influences the severity of their OA41, 49

Unlike in humans, guinea pigs resume load bearing post-operatively which accelerates joint degeneration1

The time to guinea pig skeletal maturity is fast45

Cat

Cats are larger in size allowing for tissue and fluid collection40

The full cat genome is available40

Cats are difficult and costly to manage and there are ethical issues surrounding emotional attachment40

Cats display genetic variability between individuals40

Rabbit

Naturally occurring OA is very common in rabbits52

Rabbit model useful in studying the efficacy of compounds45

Complete rabbit genome available86

Rabbits have a very different gait compared to humans and only rabbits over the age of eight or 9 months can be used to guarantee skeletal maturity52

The cartilage of rabbits is ten times thinner compared to humans, with a higher chondrocyte density and cartilage zonal layers that varies highly within the same joint87, 88

The rabbit meniscus is more cellular, has less vascular penetration and can heal faster than the human menisci89

Rabbit cartilage can spontaneously heal and regenerate and there is no complete rabbit genome available for study40

OA progression varies with the age of the rabbit after surgical OA induction, with faster progression seen in older rabbits41

Canine

Canines have similar anatomy and disease progression to humans18, 90

Canines display a widespread clinical incidence of OA18, 83

Canines are easy to manage and train postoperatively40, 45

Surgical lesions develop slowly in canines, similar to the human model1

Canines have similar gastrointestinal physiology to humans45

The canine model is widely used so comparison across different studies can be made, the larger size of canines allows for tissue and fluid collection and the full canine genome is available40

Naturally occurring OA models are available for intervention preclinical trials2, 41

Canines have different joint biomechanics and gait compared to humans, their skeletal maturity is not reached until 9 to 18 months of age and their cartilage is half the thickness of human cartilage64

There are ethical issues surrounding emotional attachment of dogs and management is costly40, 45

Canines display genetic variability between individuals40

Caprine

Anatomically the caprine stifle joint is very similar to the human knee64

The caprine stifle joint is closest in size to the human knee joint, the larger size of the animal allows for tissue and fluid collection and goat cartilage thickness is close to that of humans40

Goats are cheap and easy to use in studies compared to most large animal models and they can be used to study cartilage repair45

Complete goat genome available91

Caprine cartilage thickness varies between individuals, the skeletal maturity of a goat is not reached until at least 2 years of age and cartilage healing capacity varies with a goat's age, with better capacity in younger animals87, 92

Cartilage repair outcomes differ in the short and long term and so follow up is required to assess progress83

Naturally occurring OA in goats is uncommon40, 45

Ovine

Sheep are cheap and easy to use in studies compared to most large animal models.

The advantages of the sheep model are similar to the caprine model of OA

The disadvantages of the sheep model are very similar to the caprine model of OA

Equine

The large size of horses allows for easy tissue and fluid collection and a full genome is available40

Anatomically and histologically the equine stifle joint is similar to the human knee, the articular cartilage is very similar in thickness and the cellular structure, biochemical makeup and properties of the cartilage are most comparable to humans2, 92, 93

There are a wide range of imaging and clinical tests that can be performed on horses, including rehabilitation techniques94

Naturally occurring OA models are available45

Horses are difficult and expensive to house and manage due to their large size40

Zebrafish

Zebrafish model is useful to study gene related pathology of OA and zebrafish genome available71

Zebrafish do not have synovial joints71

Porcine

The porcine stifle joint is anatomically similar to the human knee joint and pigs have similar immune systems and gastrointestinal physiology to humans41

Pigs are most similar to humans in terms of their anatomy, neurobiology, cardiovasculature, gastrointestinal tract and genome73

Genetically modified models are available and pigs are a useful model to study repair and regeneration of focal cartilage defects73

Pigs have similar joint size, weight-bearing and cartilage thickness to humans73

The porcine meniscus is wider, and the cruciate ligaments are longer than in humans64, 95

Pig skeletal maturity is reached between 10 and 24 months of age41

Bovine

Bovine cartilage thickness, cellularity and zonal cartilage layers of patella is similar to in human femoral condyles75, 88

Bovine meniscus is biomechanically similar to the human meniscus95

Complete bovine genome available96

Bovine lateral tibial plateau cartilage is thinner, more cellular and varies in zonal cartilage thickness compared to the human75, 88

Non-human primates

Non-human primates have similar anatomy, genetics, biology, behaviour and physiology to humans2

The pathology of OA and the relationship between age and disease severity is very similar to in humans18, 76, 77

The larger size of non-human primates allows for tissue and fluid collection and the full primate genome is available for some species40

Non-human primates are expensive and ethically difficult to keep, for example chimpanzees display depression and post-traumatic stress disorder on a similar scale to that of humans97

Non-human primates have a long-life span and so a long disease pathogenesis time scale which is both time consuming and costly2

There are difficulties in obtaining adequate subject numbers for studies1

Housing and management of non-human primates is challenging40

A summary of the advantages and disadvantages of different animal models used in OA research Mice have a short life span (generally one or 2 years) and so develop OA fairly rapidly, making mice an easy model to study the whole disease process18, 43 Small animal size means the whole joint can be histologically sectioned Mice are easily managed, with low maintenance cost, demonstrate rapid disease onset and their complete genome is available for study Genetically modified mouse models are easy to produce and are useful to investigate the genetic factors involved in OA pathogenesis, specifically genes involved in cartilage degeneration, bone remodelling and inflammation18, 45 Mouse models can be used in toxicology testing and to establish the molecular basis of OA1, 45 Huge variation in results observed between different strains of mice Disease severity varies with age, with older mice more representative of human disease Difficult to ascertain skeletal maturity as growth plates often do not close completely Mice are anatomically and histologically different to humans, for example, mice have a thicker layer of calcified cartilage, do not have three distinct chondrocyte layers and have a cartilage seventy times thinner than humans Macroscopic lesions and degrees of damage are difficult to identify due to the small anatomical size of mice The progression and process of disease is faster in mice than in humans (weeks rather than decades) The small size of mice makes surgically inducing OA more challenging Postoperative management of mice is difficult in surgically induced models40, 45 Rat cartilage is thicker than that of mice, so it is possible to induce partial and full-thickness cartilage defects1, 45 Rats rarely experience post-operative infection so are useful animal models to surgically induce OA Rats are easily managed and require low maintenance costs40, 45 It is easier to perform surgery in rats than in mice due to their larger size The full rat genome is available for study MMT, MCL transection and iodoacetate models useful to study pain40, 45 Rat models useful in toxicology testing and studying cartilage restoration techniques1, 45 Naturally occurring OA is uncommon in rats, variation in results is often observed between different strains of rat and disease severity varies with age, with older rats tending to present with more severe OA It is difficult to ascertain the skeletal maturity of rats Rats have greater volumes of highly vascularised adipose tissue and muscle in the medial knee region Post-operative rats immediately resume load-bearing which accelerates joint degeneration Genetically engineered rat models are not available and postoperative management of rats is challenging The guinea pig model has similar OA histopathology to disease in humans Guinea pigs are large enough that tissue samples can be easily collected for tests and the whole joint can be histologically sectioned Guinea pigs are easy to manage Naturally occurring guinea pig models are available and the disease pathogenesis is predictable and similar to that seen in humans1, 45 -Hartley guinea pigs can be used to study risk factors for OA such as BMI and age Complete guinea pig genome available The weight of each guinea pig and whether they are housed alone or in pairs influences the severity of their OA41, 49 Unlike in humans, guinea pigs resume load bearing post-operatively which accelerates joint degeneration The time to guinea pig skeletal maturity is fast Cats are larger in size allowing for tissue and fluid collection The full cat genome is available Cats are difficult and costly to manage and there are ethical issues surrounding emotional attachment Cats display genetic variability between individuals Naturally occurring OA is very common in rabbits Rabbit model useful in studying the efficacy of compounds Complete rabbit genome available Rabbits have a very different gait compared to humans and only rabbits over the age of eight or 9 months can be used to guarantee skeletal maturity The cartilage of rabbits is ten times thinner compared to humans, with a higher chondrocyte density and cartilage zonal layers that varies highly within the same joint87, 88 The rabbit meniscus is more cellular, has less vascular penetration and can heal faster than the human menisci Rabbit cartilage can spontaneously heal and regenerate and there is no complete rabbit genome available for study OA progression varies with the age of the rabbit after surgical OA induction, with faster progression seen in older rabbits Canines have similar anatomy and disease progression to humans18, 90 Canines display a widespread clinical incidence of OA18, 83 Canines are easy to manage and train postoperatively40, 45 Surgical lesions develop slowly in canines, similar to the human model Canines have similar gastrointestinal physiology to humans The canine model is widely used so comparison across different studies can be made, the larger size of canines allows for tissue and fluid collection and the full canine genome is available Naturally occurring OA models are available for intervention preclinical trials2, 41 Canines have different joint biomechanics and gait compared to humans, their skeletal maturity is not reached until 9 to 18 months of age and their cartilage is half the thickness of human cartilage There are ethical issues surrounding emotional attachment of dogs and management is costly40, 45 Canines display genetic variability between individuals Anatomically the caprine stifle joint is very similar to the human knee The caprine stifle joint is closest in size to the human knee joint, the larger size of the animal allows for tissue and fluid collection and goat cartilage thickness is close to that of humans Goats are cheap and easy to use in studies compared to most large animal models and they can be used to study cartilage repair Complete goat genome available Caprine cartilage thickness varies between individuals, the skeletal maturity of a goat is not reached until at least 2 years of age and cartilage healing capacity varies with a goat's age, with better capacity in younger animals87, 92 Cartilage repair outcomes differ in the short and long term and so follow up is required to assess progress Naturally occurring OA in goats is uncommon40, 45 Sheep are cheap and easy to use in studies compared to most large animal models. The advantages of the sheep model are similar to the caprine model of OA The disadvantages of the sheep model are very similar to the caprine model of OA The large size of horses allows for easy tissue and fluid collection and a full genome is available Anatomically and histologically the equine stifle joint is similar to the human knee, the articular cartilage is very similar in thickness and the cellular structure, biochemical makeup and properties of the cartilage are most comparable to humans2, 92, 93 There are a wide range of imaging and clinical tests that can be performed on horses, including rehabilitation techniques Naturally occurring OA models are available Horses are difficult and expensive to house and manage due to their large size Zebrafish model is useful to study gene related pathology of OA and zebrafish genome available Zebrafish do not have synovial joints The porcine stifle joint is anatomically similar to the human knee joint and pigs have similar immune systems and gastrointestinal physiology to humans Pigs are most similar to humans in terms of their anatomy, neurobiology, cardiovasculature, gastrointestinal tract and genome Genetically modified models are available and pigs are a useful model to study repair and regeneration of focal cartilage defects Pigs have similar joint size, weight-bearing and cartilage thickness to humans The porcine meniscus is wider, and the cruciate ligaments are longer than in humans64, 95 Pig skeletal maturity is reached between 10 and 24 months of age Bovine cartilage thickness, cellularity and zonal cartilage layers of patella is similar to in human femoral condyles75, 88 Bovine meniscus is biomechanically similar to the human meniscus Complete bovine genome available Bovine lateral tibial plateau cartilage is thinner, more cellular and varies in zonal cartilage thickness compared to the human75, 88 Non-human primates have similar anatomy, genetics, biology, behaviour and physiology to humans The pathology of OA and the relationship between age and disease severity is very similar to in humans18, 76, 77 The larger size of non-human primates allows for tissue and fluid collection and the full primate genome is available for some species Non-human primates are expensive and ethically difficult to keep, for example chimpanzees display depression and post-traumatic stress disorder on a similar scale to that of humans Non-human primates have a long-life span and so a long disease pathogenesis time scale which is both time consuming and costly There are difficulties in obtaining adequate subject numbers for studies Housing and management of non-human primates is challenging

Challenges presented by current OA models

At present, there is no gold standard animal model used in OA research. Differences in size, anatomy, histology (specifically cartilage thickness) biomechanics and physiology makes translatability between animal models and human disease very difficult52, 83. Challenges are posed by species-specific differences in disease pathology and progression, as well as normal joint homeostasis, specifically the repair processes that occur within the joint. Different OA induction methods used in certain animal species also sometimes results in differences in OA presentation. There is therefore a need to reduce experimental variability and increase the reliability of data interpretation. Furthermore, different animal models have been shown to represent different stages of the disease more effectively, making selection of an animal model that completely reflects natural human disease challenging. To add to this, it has become clear that there is much dispute as to what defines OA and which molecules are associated with the disease. This is in part hindered by the fact that current ex-vivo models do not allow for the important inter-tissue communication between different joint components required for natural OA disease processes to be studied. To gain a better understanding of the mechanisms of joint damage in OA, specifically the exact sequence of events and interactions between different joint components, it has been suggested that more focus should be placed on developing 3D cell cultures and explant-based models that allow for these important interactions, providing interesting opportunities for researchers to develop their understanding of OA. In the ideal animal model, the disease must be induced reliably, with 100% penetrance, and within a suitable time frame, and yet still present with disease characteristics that are comparable to the human condition. Disease progression in the animal model should also allow for the examination of all stages of disease to ensure full detection of any therapeutic effects. The animal must be inexpensive, easy to house and manage but also be of large enough size to allow for a full range of analysis techniques to be performed. The animal must also be anatomically, biomechanically and histologically similar to humans. Some animal species, such as the canine, caprine, bovine and porcine models, are therefore better suited to OA research than others.

A promising model for OA

OA is a disease of the whole joint and therefore the gold standard model for human OA must allow for key communication between different tissues of the joint. An osteochondral (cartilage on bone) model may overcome many of the current challenges and limitations of the various models discussed above. The use of osteochondral plugs provides a model incorporating the key joint tissues affected in OA, maintaining the important interactions between these tissues as seen in human disease. There are a few studies that have used osteochondral plugs from bovine, equine and human samples as ex-vivo models of OA98, 99, 100. These osteochondral plug-based models appear very promising and so further studies should be encouraged as the basis for developing a gold standard model for OA. In the model design, cytokines such as interleukin-1 beta (IL-1β) and tumour necrosis factor alpha (TNF-α) may be used as the best method for inducing OA (cartilage damage) and tissue responses that closely replicate the natural disease, as these cytokines are known to contribute to the inflammatory effect of the synovium in the model. However, OA is a complex disease and many cytokines and chemokines have been shown to be expressed in OA synovium and detected in synovial fluid. Therefore, in the model design, investigators should consider using synovial tissue and/or synovial fluid from patients with active disease to induce OA in the osteochondral plugs. Osteochondral plugs can be harvested from joint surfaces, such as the femoral condyle, tibial plateau and patella. Methods of plug extraction available for use include different sizes of graft harvester, biopsy punch, mosaicplasty osteotome, diamond tipped cylindrical cutter or surgical trephine burr. Plugs can be cultured in serum-free culture medium such as Dulbecco's Modified Eagle Medium F-12 (DMEMF-12, Invitrogen, USA) or α-Minimum Essential Medium (α-MEM, 22,561 Gibco, The Netherlands) for up to 57 days with significant cell viability. Indeed, an early study reported that >99% chondrocyte viability can be maintained in the untraumatized areas at the centre of the osteochondral plugs. The availability of an osteochondral plug-based model, particularly a human tissue-based one, would be invaluable in screening of new disease-modifying osteoarthritis drugs (DMOADs). Currently, there are many DMOADs under different stages of development. Early studies of these drugs were in animal models, but the availability of this new model will provide an opportunity to directly test these drugs on human tissues. An osteochondral plug system like this may also be used for discovery of novel markers for OA.

Conclusion

It is clear that we are limited in our understanding of OA because we do not have a suitable model that accurately reflects natural human OA. Whilst animal models provide crucial information about disease mechanisms, none of the current models used in OA research recreate the natural in-vivo environment and allow the whole disease process to be studied. Differences in anatomy and biomechanics also makes translatability to the human model a distinct challenge. It is also important to consider the cost and ease of management of using animal models in research. Whilst smaller animal models provide many benefits in terms of availability, handling and management, larger animal models such as canines and pigs are not only more comparable to humans physiologically but also in their progression to disease. Their larger size also allows for performance of a broader range of analysis techniques and investigations. The models currently used in OA research each have their advantages and disadvantages; however, it has become clear that there are consistent problems with all of these models that hinders our ability to understand the pathogenesis of OA. The only way to achieve greater understanding of the pathological processes that underpin OA is to produce a ‘gold standard’ model for OA. Development of a consensus model will provide greater understanding of the specific stages and interactions involved in OA pathogenesis, as well as a model that can be used to compare data findings between different research groups, test pre-clinical drugs and identify and test possible biomarker targets directly on OA joint tissue. An osteochondral plug-based model could be a “promising” new model for OA, able to provide a reliable throughput model for proof of concept and mechanistic studies, aiding the discovery of targeted OA therapy. The model would also provide an opportunity to reduce the financial, ethical and time restraints associated with using animals in research, shifting OA research to embody the principle of the 3Rs; replacement, reduction and refinement of animal use in research.

Author's contributions

Conception and design: MS, KO, YL. Drafting of the article: PC, MS, KO. Provision of study materials: PC, YL. Final approval of the article: MS.

Competing interest statement

The authors declare that they have no competing interests.

Funding

Not applicable.
  93 in total

1.  Recommendations for the use of preclinical models in the study and treatment of osteoarthritis.

Authors:  R Poole; S Blake; M Buschmann; S Goldring; S Laverty; S Lockwood; J Matyas; J McDougall; K Pritzker; K Rudolphi; W van den Berg; T Yaksh
Journal:  Osteoarthritis Cartilage       Date:  2010-10       Impact factor: 6.576

2.  Animal models of osteoarthritis.

Authors:  A M Bendele
Journal:  J Musculoskelet Neuronal Interact       Date:  2001-06       Impact factor: 2.041

3.  Development of an osteoblast/osteoclast co-culture derived by human bone marrow stromal cells and human monocytes for biomaterials testing.

Authors:  C Heinemann; S Heinemann; H Worch; T Hanke
Journal:  Eur Cell Mater       Date:  2011-01-25       Impact factor: 3.942

4.  Relevance of zebrafish as an OA research model.

Authors:  P M van der Kraan
Journal:  Osteoarthritis Cartilage       Date:  2012-12-31       Impact factor: 6.576

5.  Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.

Authors:  Indira Prasadam; Ross Crawford; Yin Xiao
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

6.  Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles.

Authors:  J Malda; K E M Benders; T J Klein; J C de Grauw; M J L Kik; D W Hutmacher; D B F Saris; P R van Weeren; W J A Dhert
Journal:  Osteoarthritis Cartilage       Date:  2012-07-07       Impact factor: 6.576

7.  Assessment of the utility of biomarkers of osteoarthritis in the guinea pig.

Authors:  J L Huebner; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2006-05-05       Impact factor: 6.576

8.  Meniscus structure in human, sheep, and rabbit for animal models of meniscus repair.

Authors:  Anik Chevrier; Monica Nelea; Mark B Hurtig; Caroline D Hoemann; Michael D Buschmann
Journal:  J Orthop Res       Date:  2009-09       Impact factor: 3.494

9.  Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis.

Authors:  Roberto E Guzman; Mark G Evans; Susan Bove; Brandy Morenko; Kenneth Kilgore
Journal:  Toxicol Pathol       Date:  2003 Nov-Dec       Impact factor: 1.902

10.  A review of translational animal models for knee osteoarthritis.

Authors:  Martin H Gregory; Nicholas Capito; Keiichi Kuroki; Aaron M Stoker; James L Cook; Seth L Sherman
Journal:  Arthritis       Date:  2012-12-27
View more
  42 in total

1.  Combined Mesenchymal Stem Cells and Cartilage Acellular Matrix Injection Therapy for Osteoarthritis in Goats.

Authors:  Mijin Kim; Jongchan Ahn; Jusik Lee; Seongsoo Song; Seunghee Lee; Seunghee Lee; Kyung-Sun Kang
Journal:  Tissue Eng Regen Med       Date:  2022-01-13       Impact factor: 4.169

2.  Preclinical Models of Elbow Injury and Pathology.

Authors:  Michael A David; Aaron M Chamberlain; Spencer P Lake
Journal:  Ann Jt       Date:  2021-01-15

3.  Hypoxia Inducible Factor-1α Is a Regulator of Autophagy in Osteoarthritic Chondrocytes.

Authors:  Junren Lu; Yi Peng; Jiapeng Zou; Jiayi Wang; Shunyi Lu; Tengfei Fu; Libo Jiang; Chi Zhang; Jian Zhang
Journal:  Cartilage       Date:  2021-08-28       Impact factor: 3.117

Review 4.  Naturally Occurring Osteoarthritis Features and Treatments: Systematic Review on the Aged Guinea Pig Model.

Authors:  Francesca Veronesi; Francesca Salamanna; Lucia Martini; Milena Fini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

5.  Evaluation of serum MMP-2 and MMP-3, synovial fluid IL-8, MCP-1, and KC concentrations as biomarkers of stifle osteoarthritis associated with naturally occurring cranial cruciate ligament rupture in dogs.

Authors:  Sarah Malek; Hsin-Yi Weng; Shannon A Martinson; Mark C Rochat; Romain Béraud; Christopher B Riley
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

Review 6.  Two-Dimensional and Three-Dimensional Cartilage Model Platforms for Drug Evaluation and High-Throughput Screening Assays.

Authors:  Nicola C Foster; Nicole M Hall; Alicia J El Haj
Journal:  Tissue Eng Part B Rev       Date:  2021-05-19       Impact factor: 6.389

Review 7.  Current Models for Development of Disease-Modifying Osteoarthritis Drugs.

Authors:  Meagan J Makarczyk; Qi Gao; Yuchen He; Zhong Li; Michael S Gold; Mark C Hochberg; Bruce A Bunnell; Rocky S Tuan; Stuart B Goodman; Hang Lin
Journal:  Tissue Eng Part C Methods       Date:  2021-02-04       Impact factor: 3.056

8.  Ginkgolide J protects human synovial cells SW982 via suppression of p38‑dependent production of pro‑inflammatory mediators.

Authors:  Yujie Zhao; Yuan Chen; Jiayi Wang; Xue Zhu; Ke Wang; Yue Li; Fanfan Zhou
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

9.  Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs.

Authors:  Ning Wang; Yuchen He; Silvia Liu; Meagan J Makarcyzk; Guanghua Lei; Alexander Chang; Peter G Alexander; Tingjun Hao; Anne-Marie Padget; Nuria de Pedro; Tsapekos Menelaos; Hang Lin
Journal:  Sci China Life Sci       Date:  2021-06-04       Impact factor: 6.038

10.  Photobiomodulation Therapy Partially Restores Cartilage Integrity and Reduces Chronic Pain Behavior in a Rat Model of Osteoarthritis: Involvement of Spinal Glial Modulation.

Authors:  Gustavo Balbinot; Clarissa Pedrini Schuch; Patricia Severo do Nascimento; Fabio Juner Lanferdini; Mayra Casanova; Bruno Manfredini Baroni; Marco Aurélio Vaz
Journal:  Cartilage       Date:  2019-09-30       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.